课题基金 / 基金详情

MOZ regulates cellular senescence

MOZ regulates cellular senescence
MOZ 调节细胞衰老
批准号:
nhmrc : 1084509
负责人:
A/Pr Anne Voss
金额:
$33.24万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2017-12-31

项目摘要

项目成果

A/Pr Anne Voss的其他基金

相似基金

相关文献

中文摘要
翻译
我们最近发现,MOZ(单核细胞白血病锌指基因)是衰老的主要调节因子,该基因首次在导致一种特别侵袭性白血病的突变中被发现。在缺乏MOZ的情况下,细胞退出细胞周期并变得衰老,而不受DNA损伤的影响。这些观察结果对于了解癌症的发展非常重要,因为癌症的生长和扩散必须避免细胞衰老。
英文摘要
We have recently discovered that MOZ (monocytic leukaemia zinc finger gene), a gene first identified in rmutations leading to a particularly aggressive form of leukaemia, is a major regulator of senescence. In the absence of MOZ cells exit the cell cycle and become senescent, independently of DNA damage. These obsevations are very important for understanding cancer development because for cancer to grow and spread the cells must avoid senescence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The molecular and biological roles of growth inhibiting chromatin binding proteins
  • 批准号:
    nhmrc : GNT1143612
  • 项目类别:
    Project Grants
  • 资助金额:
    $81.48万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Anne Voss
  • 依托单位:
The molecular and biological roles of growth inhibiting chromatin binding proteins
Regulation of haematopoietic stem cells through histone modifications
Chromatin regulation of neural stem cell multipotency
海外基金